Le co-développement des R&D vaccinales et bio-informatiques au sein des grands groupes pharmaceutiques : une double lecture structurale (notice n° 2079454)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02725cam a2200289 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260405004922.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Lebert, Didier |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Le co-développement des R&D vaccinales et bio-informatiques au sein des grands groupes pharmaceutiques : une double lecture structurale |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2027.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 1 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | L’article analyse comment huit groupes biopharmaceutiques articulent la bio-informatique et la vaccinologie dans leurs processus de R&D à la veille de la crise de la COVID-19. Pour ce faire, deux lectures structurales sont utilisées : des graphes de citations pour retracer les interdépendances technologiques et des graphes de co-présences pour mesurer la cohérence interne des bases de connaissances de ces entreprises. La notion de co-développement constitue le cœur conceptuel, méthodologique et empirique de l’étude. Les résultats révèlent une forte hétérogénéité dans le choix des formes du co-développement technologique dans ces entreprises. La bio-informatique sert surtout d’input ponctuel pour plusieurs d’entre elles. Une boucle d’amélioration continue entre bio-informatique et vaccins n’apparaît que chez Sanofi. Cette entreprise est également la seule à inclure ces technologies dans la même communauté cohérente de brevets. Code JEL : O32, L65 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This article analyses how eight pharmaceutical groups combine bioinformatics and vaccinology in their R&D processes. To achieve this, two structural approaches are employed: citation graphs are used to trace technological interdependencies, while co-presence graphs measure the internal coherence of these companies’ knowledge bases. The notion of co-development constitutes the conceptual, methodological and empirical core of the study. The results reveal a high degree of heterogeneity in the choice of technological co-development forms in these companies. Bioinformatics is primarily employed as a input. A continuous improvement loop between bioinformatics and vaccines only appears at Sanofi. Sanofi is also the only company to include these technologies in the same coherent patent community. Code JEL: O32, L65 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Bio-informatique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Brevets |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Graphes de citations |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Graphes de cooccurrences |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Vaccinologie |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Bioinformatics |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Citation Graphs |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Co-occurrence Graphs |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Patents |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Vaccinology |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Innovations | Pub. anticipées | 2027-04-17 | p. I203-XXXV | 1267-4982 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-innovations-2026-0-page-I203?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-innovations-2026-0-page-I203?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux